Heska (Restricted Voting) 

$119.99
2
+$0.05+0.04% Monday 20:00

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
1.3B
本益比
-44.92
股息殖利率
-
股息
-

股息

0%股息殖利率
Oct 12
$0.1
Jul 12
$0.1
Apr 12
$0.1
10年成長
不適用
5年成長
不適用
3年成長
不適用
1年成長
不適用

財報

7Aug預期
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.97
-0.46
0.04
0.55
預期EPS
-0.22
實際EPS
不適用

財務

-7.45%利潤率
未盈利
2017
2018
2019
2020
2021
2022
323.65M營收
-24.11M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 HSKA 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Health Technology
Medical Specialties
Manufacturing
Biological Product (except Diagnostic) Manufacturing
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
Show more...
執行長
Kevin Wilson
員工
655
國家
US
ISIN
US42805E3062
WKN
000A1H5J3

上市

0 Comments

分享你的想法

FAQ

Heska (Restricted Voting) 今天的股價是多少?
HSKA 目前價格為 $119.99 USD,過去 24 小時上漲了 +0.04%。在圖表上更密切關注 Heska (Restricted Voting) 股價表現。
Heska (Restricted Voting) 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Heska (Restricted Voting) 的股票以代號 HSKA 進行交易。
Heska (Restricted Voting) 的市值是多少?
今天 Heska (Restricted Voting) 的市值為 1.3B
Heska (Restricted Voting) 去年的營收是多少?
Heska (Restricted Voting) 去年的營收為 323.65MUSD。
Heska (Restricted Voting) 去年的淨利是多少?
HSKA 去年的淨收益為 -24.11MUSD。
Heska (Restricted Voting) 會發放股息嗎?
是的,HSKA 的股息每 每季 發放一次。每股最新股息為 0.1 USD。截至今日,股息殖利率(FWD)% 為 0%。
Heska (Restricted Voting) 有多少名員工?
截至 April 01, 2026,公司共有 655 名員工。
Heska (Restricted Voting) 位於哪個產業?
Heska (Restricted Voting)從事於Manufacturing產業。
Heska (Restricted Voting) 何時完成拆股?
Heska (Restricted Voting) 最近沒有進行任何拆股。
Heska (Restricted Voting) 的總部在哪裡?
Heska (Restricted Voting) 的總部位於 US 的 Loveland。